These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33215550)

  • 1. Short-Term Variability of the QT Interval Can be Used for the Prediction of Imminent Ventricular Arrhythmias in Patients With Primary Prophylactic Implantable Cardioverter Defibrillators.
    Smoczyńska A; Loen V; Sprenkeler DJ; Tuinenburg AE; Ritsema van Eck HJ; Malik M; Schmidt G; Meine M; Vos MA
    J Am Heart Assoc; 2020 Dec; 9(23):e018133. PubMed ID: 33215550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal Changes in Beat-to-Beat Variability of Repolarization Predict Imminent Nonsustained Ventricular Tachycardia in Patients With Ischemic and Nonischemic Dilated Cardiomyopathy.
    Amoni M; Ingelaere S; Moeyersons J; Vandenberk B; Claus P; Lemmens R; Van Huffel S; Sipido K; Varon C; Willems R
    J Am Heart Assoc; 2022 Jul; 11(13):e024294. PubMed ID: 35730633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W; Christ M; Bach J; Müller HH; Maisch B
    Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term variability of repolarization predicts ventricular tachycardia and sudden cardiac death in patients with structural heart disease: a comparison with QT variability index.
    Oosterhoff P; Tereshchenko LG; van der Heyden MA; Ghanem RN; Fetics BJ; Berger RD; Vos MA
    Heart Rhythm; 2011 Oct; 8(10):1584-90. PubMed ID: 21699842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of Tp-e interval and Tp-e/Q-T ratio with malignant ventricular arrhythmia in patients with implantable cardioverter-defibrillator for primary prevention].
    Zhu TY; Teng SE; Chen YY; Liu SR; Meng SR; Peng J
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):401-4. PubMed ID: 27063171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy: the importance of arrhythmic events in patients at risk for sudden cardiac death.
    Medeiros Pde T; Martinelli Filho M; Arteaga E; Costa R; Siqueira S; Mady C; Piegas LS; Ramires JA
    Arq Bras Cardiol; 2006 Nov; 87(5):649-57. PubMed ID: 17221043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: Prognostic value and heart rate variability evolution.
    Gamet A; Degand B; Le Gal F; Bidegain N; Delaubier A; Gilbert-Dussardier B; Christiaens L; Garcia R
    Ann Noninvasive Electrocardiol; 2019 Jan; 24(1):e12587. PubMed ID: 30101452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.
    Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Sędkowska A; Cebula S; Musialik-Łydka A; Kalarus Z
    Kardiol Pol; 2012; 70(5):447-55. PubMed ID: 22623232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
    Wang W; Lian Z; Rowin EJ; Maron BJ; Maron MS; Link MS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of ambulatory ECG monitoring for ventricular arrhythmias.
    Katritsis DG; Siontis GC; Camm AJ
    Prog Cardiovasc Dis; 2013; 56(2):133-42. PubMed ID: 24215745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
    Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate variability density analysis (Dyx) for identification of appropriate implantable cardioverter defibrillator recipients among elderly patients with acute myocardial infarction and left ventricular systolic dysfunction.
    Jørgensen RM; Levitan J; Halevi Z; Puzanov N; Abildstrøm SZ; Messier MD; Huikuri HV; Haarbo J; Thomsen PE; Jons C;
    Europace; 2015 Dec; 17(12):1848-54. PubMed ID: 25755288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiographic Markers of Appropriate Implantable Cardioverter-Defibrillator Therapy in Young People with Congenital Heart Diseases.
    Benítez Ramos DB; Cabrera Ortega M; Castro Hevia J; Dorantes Sánchez M; Alemán Fernández AA; Castañeda Chirino O; Cruz Cardentey M; Martínez López F; Falcón Rodríguez R
    Pediatr Cardiol; 2017 Dec; 38(8):1663-1671. PubMed ID: 28871362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction.
    Haugaa KH; Grenne BL; Eek CH; Ersbøll M; Valeur N; Svendsen JH; Florian A; Sjøli B; Brunvand H; Køber L; Voigt JU; Desmet W; Smiseth OA; Edvardsen T
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):841-50. PubMed ID: 23850251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmias in hypertrophic cardiomyopathy.
    Kuck KH
    Pacing Clin Electrophysiol; 1997 Oct; 20(10 Pt 2):2706-13. PubMed ID: 9358518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
    Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsustained ventricular tachycardia and other high-risk predictors following myocardial infarction: implications for prophylactic automatic implantable cardioverter-defibrillator use.
    Wilber DJ; Kopp D; Olshansky B; Kall JG; Kinder C
    Prog Cardiovasc Dis; 1993; 36(3):179-94. PubMed ID: 8234772
    [No Abstract]   [Full Text] [Related]  

  • 20. The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy.
    Dinshaw L; Münch J; Dickow J; Lezius S; Willems S; Hoffmann BA; Patten M
    Clin Res Cardiol; 2018 Feb; 107(2):130-137. PubMed ID: 28965260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.